As of 2025-11-05, the Relative Valuation of Karyopharm Therapeutics Inc (KPTI) is (213.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.65 USD, the upside of Karyopharm Therapeutics Inc based on Relative Valuation is -3887.1%.
The range of the Relative Valuation is (197.61) - (190.94) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 14.3x | 14.2x |
| Forward P/E multiples | 14.8x - 20.9x | 17.8x |
| Fair Price | (197.61) - (190.94) | (213.97) |
| Upside | -3597.6% - -3479.4% | -3887.1% |
| Date | P/E |
| 2025-11-03 | -0.45 |
| 2025-10-31 | -0.43 |
| 2025-10-30 | -0.45 |
| 2025-10-29 | -0.46 |
| 2025-10-28 | -0.47 |
| 2025-10-27 | -0.48 |
| 2025-10-24 | -0.47 |
| 2025-10-23 | -0.46 |
| 2025-10-22 | -0.46 |
| 2025-10-21 | -0.48 |
| 2025-10-20 | -0.48 |
| 2025-10-17 | -0.44 |
| 2025-10-16 | -0.45 |
| 2025-10-15 | -0.45 |
| 2025-10-14 | -0.43 |
| 2025-10-13 | -0.42 |
| 2025-10-10 | -0.41 |
| 2025-10-09 | -0.44 |
| 2025-10-08 | -0.44 |
| 2025-10-07 | -0.43 |
| 2025-10-06 | -0.46 |
| 2025-10-03 | -0.48 |
| 2025-10-02 | -0.47 |
| 2025-10-01 | -0.47 |
| 2025-09-30 | -0.49 |
| 2025-09-29 | -0.48 |
| 2025-09-26 | -0.49 |
| 2025-09-25 | -0.50 |
| 2025-09-24 | -0.52 |
| 2025-09-23 | -0.56 |
| 2025-09-22 | -0.44 |
| 2025-09-19 | -0.41 |
| 2025-09-18 | -0.43 |
| 2025-09-17 | -0.46 |
| 2025-09-16 | -0.47 |
| 2025-09-15 | -0.47 |
| 2025-09-12 | -0.48 |
| 2025-09-11 | -0.50 |
| 2025-09-10 | -0.47 |
| 2025-09-09 | -0.47 |
| 2025-09-08 | -0.47 |
| 2025-09-05 | -0.49 |
| 2025-09-04 | -0.50 |
| 2025-09-03 | -0.53 |
| 2025-09-02 | -0.51 |
| 2025-08-29 | -0.53 |
| 2025-08-28 | -0.58 |
| 2025-08-27 | -0.58 |
| 2025-08-26 | -0.56 |
| 2025-08-25 | -0.47 |